Amoeba (PAR: ALMIB)

Last close As at 13/12/2024

EUR1.02

0.15 (17.65%)

Market capitalisation

EUR44m

Amoéba is a greentech based in France, which aims to become a major player in treating microbiological risk in the crop protection and cosmetic sectors. Based on the natural properties of a unique, exclusively patented microorganism, its biological solutions offer a viable alternative to the chemical products widely used in the industry today.

Latest Insights

View More

Industrials | Outlook

Amoeba — Focused on high-value opportunities

Industrials | Update

Amoeba — Biocontrol plant paves path to commercialisation

Industrials | Update

Amoeba — Scaling up for commercialisation

Industrials | Update

Amoeba — Building on an exceptional year

Sector

Industrials

Equity Analyst

Michael McNamara

Analyst, Industrials

Key Management

  • Benoit Villers

    Chairman

  • Jean-Francois Doucet

    CEO

Research

Update

Industrials

Amoeba — Building on an exceptional year

edison tv

Industrials

Amoeba – executive interview

Initiation

Industrials

Amoeba — Fighting pathogens, respecting nature

Thematics

thematic

Energy & Resources

Renewable energy developers – Creating value for investors

thematic

Industrials

The art of measurement – Challenges in metrology

thematic

Industrials

Deutsches Eigenkapitalforum (EKF) 2023 industrials

thematic

Industrials

The long and winding road

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free